Register for the 2018 Symposium
The Washington University NF Center will be hosting its fourth biennial NF Center Symposium on September 5, 2018 in the Eric P. Newman Education Center on the Medical School Campus. In addition to our two keynote speakers, Drs. Frank McCormick and Eric Legius, we are delighted to showcase research and clinical advances made by some of our faculty in the Washington University NF Center.
Eric Legius, MD, PhD is Professor of Human Genetics at the University of Leuven, Belgium. He and his colleagues have been leaders in characterizing NF1-like syndromes, and in identifying genotype-phenotype correlations important for precision medicine.
Frank McCormick, PhD is Professor of the UCSF Helen Diller Family Comprehensive Cancer Center and holds the David A. Wood Chair of Tumor Biology and Cancer Research at UCSF. He and his team were one of the first to define the role of RAS in human disease, and to demonstrate that the NF1 protein is a key regulator of RAS.
David H. Gutmann, MD, PhD is the Donald O. Schnuck Family Professor and Vice Chair for Research Affairs in the Department of Neurology at Washington University. He established and currently directs the Washington University NF Center. Dr. Gutmann is one of the world’s leading experts on NF.
Philip Payne, PhD, FACMI is the founding director of the Institute for Informatics at Washington University, where he serves as the Robert J. Terry Professor. Dr. Payne is an internationally recognized leader in the field of clinical research informatics and translational bioinformatics.
John Constantino, MD is the Blanche F. Ittleson Professor of Psychiatry and Pediatrics and Director of the William Greenleaf Eliot Division of Child & Adolescent Psychiatry. In addition, he serves as the Director of the Intellectual and Developmental Disability Research Center at Washington University. Dr. Constantino is an international authority on autism.
Angie Hirbe, MD, PhD is an Assistant Professor in Medical Oncology at the Washington University School of Medicine. Dr. Hirbe directs a translational research laboratory focused on developing more effective therapies for malignant peripheral nerve sheath tumors (MPNSTs). As one of the recipients of the Francis S. Collins Neurofibromatosis Scholar Award, her clinical practice is focused on the care of adults with NF1-associated plexiform neurofibromas and MPNSTs.
Robert C. McKinstry, MD, PhD is the William R. Orthwein, Jr. and Laura Rand Orthwein Professor of Radiology and Chief of Pediatric Radiology at St. Louis Children’s Hospital. Dr. McKinstry is an international expert on pediatric neuro-radiology and advanced applications of magnetic resonance imaging (MRI).
Stephanie M. Morris, MD is an Assistant Professor in Pediatric Neurology at the Washington University School of Medicine. She is the co-director of the Neurofibromatosis Clinical Program at St. Louis Children’s Hospital. Dr. Morris is the leader of the International NF Autism Collaborative Team (INFACT) and an authority on NF1 developmental disabilities.
Courtney Dunn, PT/DPT graduated from the University of Missouri-Columbia with a Bachelor’s degree in physical therapy and then completed her Doctorate of Physical Therapy with an emphasis in pediatrics. Dr. Dunn provides physical therapy services and resources for children with NF1, including outpatient therapy, school-based services and community-based services. Courtney has researched motor delays in children with NF1, and based on her findings, established Club NF, a play-based therapy program for children with NF1. In addition, with our partners at Jazz St. Louis, she has designed a jazz music motor therapy program for toddlers with NF1.
Nicole Weckherlin, OT/OTRL received her BS in Occupational Therapy from St. Louis University. She is a licensed and registered occupational therapist currently working in the Cerebral Palsy and Neurofibromatosis Clinical Programs at St. Louis Children’s Hospital. Based on her success using iPAD Apps to address delays in children with NF1, Nicole has launched an Apps Therapy Program at St. Louis Children’s Hospital.